Lo screening di Fabry nei pazienti con CKD di eziologia incerta e in terapia sostitutiva renale è una strategia efficace per identificare casi non...

Molte malattie metaboliche ereditarie possono essere diagnosticate a partire dai 65 anni.

Biomarcatori plasmatici come MCP-1, YKL-40 e Cistatina C offrono nuove prospettive sul monitoraggio della malattia di Fabry.

Questo studio evidenzia il potenziale del NBGS nel favorire la diagnosi precoce di LSD presintomatiche, permettendo interventi tempestivi e migliori...

This makes an interdisciplinary approach mandatory for the management of these patients, to provide the best care possible based on tumor size, site...

This study interrogated the preresection biopsies of a cohort of osteosarcoma and chondrosarcoma with SATB2 and SOX9 in tandem

In summary, potential serum biomarkers for OS diagnosis and metastatic prediction were identified based on an analysis of immune cell infiltration

To find such probes, the cell-Systematic Evolution of Ligands by EXponential enrichment (cell-SELEX) methodology was implemented against the human...

It is necessary to establish a method to identify patients diagnosed with OS at an early stage. It is becoming obvious that anti-tumor-associated...